Who Buys K-Beauty Brands? The 2026 Acquisition Trend, Explained
Quick Answer
Three kinds of buyers pay for K-beauty brands: global groups such as L'Oréal, Korean groups such as Amorepacific and Goodai Global, and private-equity roll-ups. They pay for growth, margin and repeat customers. Then they check what the brand truly owns. For a brand made by a Korean manufacturer, that check starts with the formula and the supply contract.
Most founders plan the launch. Few plan the sale. Yet the sale price is shaped by first-year choices: whose name is on the trademark, who holds the formula, and what your manufacturing contract says about a new owner.
The buyer side is busy. Korea exported a record $11.4 billion of cosmetics in 2025. The United States overtook China as its largest market, at $2.2 billion (MFDS data reported by Korea JoongAng Daily). Brands riding that wave now draw offers from three kinds of buyers.
This brief maps who is buying, what the disclosed deals show, and what an acquirer will ask about a brand made by a Korean ODM.
Key Takeaways
- Global strategics, Korean groups and private-equity roll-ups are the three main buyers of K-beauty brands, and each pays for something different.
- Disclosed prices run from a premium for breakout brands to low single-digit EBITDA multiples for smaller ones.
- For a brand made by a Korean ODM, the manufacturing contract is part of what gets sold: formula rights, exclusivity and assignment all get checked.
- Under MoCRA, the buyer inherits FDA duties for products already on shelf, so registrations, listings, safety records and adverse event files get reviewed.
Who Is Actually Buying K-Beauty Brands?
Three groups do most of the buying. Global strategics buy brands that fill a gap in their portfolios. Korean groups buy fast-growing indie brands to build K-beauty portfolios of their own. Platforms backed by private equity buy smaller brands and run them on a shared back office.
A strategic acquirer is a company that buys a brand to run it inside its own business, not to resell it. A roll-up is a platform that buys many small brands and shares finance, logistics and marketing across them.
| Buyer type | Example deal | What was disclosed |
|---|---|---|
| Global strategic | Unilever bought Carver Korea, maker of AHC (2017) | €2.27 billion; Carver had €321 million in 2016 sales (Cosmetics Business) |
| Global strategic | Estée Lauder bought the rest of Have & Be, owner of Dr.Jart+ (2019) | Have & Be valued at about $1.7 billion (Estée Lauder filing) |
| Global strategic | L'Oréal agreed to buy Gowoonsesang Cosmetics, owner of Dr.G, from Migros (reported January 2025) | Price not disclosed; L'Oréal's second Korean brand after 3CE (Cosmetics Business) |
| Korean strategic | Amorepacific took control of COSRX (2023) | KRW 755.1 billion for more shares, lifting its stake to a planned 93.2 percent (Amorepacific release) |
| Korean holding group | Goodai Global, owner of Beauty of Joseon, TIRTIR and Skinfood | IMM Private Equity and five other Korean investors set to put in KRW 800 billion ($600 million) to fund more deals (KED Global) |
| Roll-up platform | Skyline Beauty Group bought LilyAna Naturals (2026) | Terms not disclosed; targets brands with $5 million to $50 million in sales at roughly 3X to 4X EBITDA (Beauty Independent) |
| US strategic (benchmark) | e.l.f. Beauty agreed to buy rhode (2025) | Up to $1 billion, including a $200 million earnout; rhode had $212 million in net sales (e.l.f. release) |
K-Beauty's Export Boom Brought the Buyers In
Buyers follow categories that grow outside their home market, and K-beauty now does. Korea's 2025 cosmetics exports rose 11.8 percent to a record $11.4 billion, and skincare made up about three quarters of the total (Korea JoongAng Daily, citing MFDS).
Two other shifts matter for founders. First, Korean groups now compete with global strategics. Goodai Global's 2025 fundraising valued it at about KRW 4 trillion, roughly nine times forward EBITDA, and the money was raised to buy more brands (KED Global). In early 2026 it agreed to buy control of Hansung USA for about KRW 100 billion (Seoul Economic Daily). Hansung places Korean brands with US retailers.
Second, the ODM model lets a brand scale without its own plant. Cosmax and Kolmar Korea each produced more than KRW 1 trillion of cosmetics in 2025 (MFDS production data). A buyer can add volume through the same factories, if the contract allows it.
What Do Acquirers Actually Pay For?
Acquirers pay for growth they can extend, margins they can keep and customers who come back. Price follows those three, which is why disclosed multiples vary so much between a breakout brand and a steady small one.
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of operating profit. A multiple is the price divided by that figure, or by sales. At the top end, rhode sold for up to $1 billion after $212 million in twelve-month net sales (e.l.f. Beauty). At the other end, Skyline Beauty Group aims to pay roughly 3X to 4X EBITDA for brands with $5 million to $50 million in sales (Beauty Independent).
An earnout is part of the price paid later, only if the brand hits agreed targets. In the rhode deal, $200 million of the headline price depended on growth over three years (e.l.f. Beauty). Earnouts keep founders involved after closing, so read one as a job description as well as a price.
Four things lift the price:
- Growth that does not hang on one channel. Your own site, retail and a marketplace together beat a single platform.
- Margin that survives a new owner. Our K-beauty wholesale pricing and margin guide shows where margin leaks first.
- Repeat customers. Reorder rates and reviews are proof a buyer can check.
- Assets the company owns outright. Trademarks, formula rights and test data in the brand's name.
"I'm Liz, I run altameet from Manhattan, NYC. When founders ask me about an exit, I point them first to their manufacturing agreement: who owns the formula, and can the contract pass to a new owner? If you want a quick gut-check on your ODM setup, I'll give you 15 minutes free."
Your Korean ODM Contract Is Part of the Deal
When a Korean ODM makes your product, a buyer is also buying that supply relationship. An ODM, or original development manufacturer, is a contract manufacturer that develops the formula as well as producing it. That model is efficient at launch. At sale, the buyer will ask who owns the formula and whether the contract survives a change of owner.
Deal structure raises the stakes. Skyline, for example, buys assets rather than company shares (Beauty Independent). In an asset purchase, each trademark, formula right and contract has to move to the buyer one by one. Contracts that restrict assignment need the other party's consent to move.
Formula ownership is a contract term, not a default. Some agreements give the brand the formula, some keep it with the manufacturer, and many leave it unclear. Our comparison of off-the-shelf vs custom Korean ODM formulas explains why a stock base and a custom formula carry different rights.
What a buyer asks about an ODM setup, and what to have ready:
| Item | Buyer's question | What to have ready |
|---|---|---|
| Formula rights | Who owns the formula and the full percentages? | A clause on formula ownership or a written transfer option, plus the full formula on file |
| Assignment | Can the manufacturing agreement pass to a new owner? | An assignment or change-of-control clause that allows a sale |
| Exclusivity | Can the factory sell your formula to others? | An exclusivity term, or a written note that it is a stock base |
| Supply terms | What happens if prices rise or the factory drops you? | Price-change notice, last-order rights and a second-source plan |
| Quality records | Are batches consistent and documented? | Certificates of analysis, stability reports and complaint logs |
| Claims evidence | Can every label claim be backed? | Test reports issued in the brand's name (see our guide to HRIPT, clinical and consumer testing) |
These terms are easy to raise at the start and hard to win later. See what Korean ODMs won't tell you before signing.
What Will a Buyer Check Under MoCRA?
A buyer checks that every US product meets MoCRA, because it inherits the duties for products already on the market. Facilities that make cosmetics for the US must register with FDA and renew every two years, unless a small-business exemption applies. The responsible person must list each product, report serious adverse events within 15 business days and keep records that support product safety (FDA).
The responsible person is the company whose name appears on the label as manufacturer, packer or distributor. If that name belongs to a distributor or to a founder's other company, fix it before any sale.
MoCRA also gave FDA records access and mandatory recall authority (FDA). For a buyer, a missing listing or an empty adverse event log is a liability that comes with the brand. Our FDA guide to importing Korean skincare covers the import side of the same file.
Seven Steps to an Exit-Ready K-Beauty Brand
Exit-ready means the company, not the founder or the factory, owns what the buyer is paying for. These seven steps cost little in year one and are slow to fix during a deal.
- Map ownership. List every asset a buyer would value and whose name it sits in.
- Register trademarks in the company's name. Start with the US (USPTO) and Korea (KIPO).
- Fix the ODM agreement. Settle formula ownership, exclusivity and assignment before your next large order.
- Keep one regulatory file per market. Registrations, listings, safety records and adverse event logs, all current.
- Hold claims evidence in the brand's name. A report addressed to the factory is weaker proof.
- Spread your channels. Skyline's stated plan for LilyAna is to cut its Amazon reliance and grow brand-owned e-commerce (Beauty Independent). Our US launch and distribution playbook maps the channel options.
- Track margin by SKU. A buyer wants to see which products carry the business.
What Lowers a K-Beauty Brand's Sale Price?
Buyers discount value that sits outside the company. The three common leaks are a formula the brand cannot take with it, one channel driving most sales, and gaps in compliance records.
- Formula lock-in. If the factory owns the formula, the buyer cannot move production. The brand's value then rests on the manufacturer's goodwill.
- Channel dependence. When one retailer or marketplace drives most sales, a single policy change can cut revenue.
- Compliance gaps. Missing listings, thin safety files or unlogged complaints can turn into price cuts or special indemnities in the purchase agreement.
Exit-Ready Brand Checklist
Get the exit-ready checklist for ODM-made brands as a free PDF, straight to your inbox.
Frequently Asked Questions
Can I sell my K-beauty brand if my manufacturer owns the formula?
Yes, but the buyer will price in that dependence. Buyers typically ask for a long-term supply agreement, an exclusivity term or a formula transfer option before closing.
What is an earnout in a beauty acquisition?
An earnout is part of the purchase price paid after closing, only if the brand meets agreed targets. It lets a buyer pay for growth it has not seen yet, and it keeps the founder involved.
Do buyers care which Korean manufacturer made the product?
They care more about the terms and the records than the factory's name. A buyer wants proof of consistent quality, FDA facility registration where required, and supply that continues after the sale.
When should a founder start preparing for an exit?
At the first manufacturing contract. Formula rights, exclusivity and assignment terms are easiest to set before production starts. Once the brand depends on one factory, they are harder to win.
By Liz Song, K-beauty sourcing consultant.